Delivery Order SPE2DB22D2206-SPE2DB25FJE95
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,779.46 to AmerisourceBergen Drug Corp for Januvia 100 mg tablets (90-count supply) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract for delivery to the vendor's corporate headquarters location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $3,274.38. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a continuation of the company's pharmaceutical supply relationship with DLA. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $2,728.65 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $1,106.86. This non-set-aside delivery order is scheduled for completion by August 11, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The place of performance is located at the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,091.46 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement for pharmaceutical supply to federal medical systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under its...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Januvia 50 mg tablets (90-count) with a contract value of $1,262.81. This delivery order operates under a firm fixed-price arrangement with an ultimate completion date of August 4, 2025. The contract was awarded competitively with no set-aside designation and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count) under a firm fixed-price contract type. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a ceiling value of $10,411.20 and an ultimate completion date of August 5, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJE95Delivery Order
The Defense Logistics Agency awarded a $1,789.43 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Januvia 25 mg tablets (90-count units). This firm fixed price, competitively awarded contract is not set-aside and has an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a prime vendor vehicle valued at $999,999,999.00 and running through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. This award reflects typical transactional activity under the DLA's pharmaceutical supply chain, through which AmerisourceBergen Drug Corp delivers brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. As a critical vendor in the federal medical procurement ecosystem, AmerisourceBergen Drug Corp has demonstrated consistent capability to fulfill federal requirements through open competition, with contract values ranging substantially based on operational needs and medical supply demand across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/1/25 |